Arife Ulaş

737 total citations
46 papers, 492 citations indexed

About

Arife Ulaş is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Arife Ulaş has authored 46 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Arife Ulaş's work include Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Diagnosis and Treatment (6 papers). Arife Ulaş is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Diagnosis and Treatment (6 papers). Arife Ulaş collaborates with scholars based in Türkiye, Cambodia and United Kingdom. Arife Ulaş's co-authors include Berna Öksüzoğlu, Kamile Sılay, Necati Alkış, Nilüfer Avcı, Fatma Paksoy Türköz, Erdem Çubukçu, Şuayib Yalçın, Ayşe Durnalı, Saadettin Kılıçkap and Mustafa Solak and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Arife Ulaş

44 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arife Ulaş Türkiye 12 301 201 100 81 69 46 492
Danila Comandini Italy 11 269 0.9× 191 1.0× 88 0.9× 37 0.5× 29 0.4× 31 446
Zachary Burningham United States 8 243 0.8× 349 1.7× 89 0.9× 63 0.8× 89 1.3× 36 617
P. Foa Italy 13 244 0.8× 138 0.7× 149 1.5× 37 0.5× 44 0.6× 26 507
Gina Villani United States 10 214 0.7× 133 0.7× 49 0.5× 53 0.7× 67 1.0× 24 456
A.C. Braud France 13 483 1.6× 192 1.0× 198 2.0× 167 2.1× 55 0.8× 23 739
Paul Donnellan Ireland 12 381 1.3× 156 0.8× 73 0.7× 104 1.3× 82 1.2× 33 584
Yukiya Narita Japan 14 374 1.2× 363 1.8× 171 1.7× 43 0.5× 69 1.0× 98 732
Alfonso Yubero Spain 13 486 1.6× 125 0.6× 53 0.5× 44 0.5× 57 0.8× 45 584
Olivier Capitain France 15 535 1.8× 269 1.3× 160 1.6× 47 0.6× 115 1.7× 59 826
Frédéríc Gomez France 11 160 0.5× 217 1.1× 125 1.3× 61 0.8× 80 1.2× 23 425

Countries citing papers authored by Arife Ulaş

Since Specialization
Citations

This map shows the geographic impact of Arife Ulaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arife Ulaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arife Ulaş more than expected).

Fields of papers citing papers by Arife Ulaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arife Ulaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arife Ulaş. The network helps show where Arife Ulaş may publish in the future.

Co-authorship network of co-authors of Arife Ulaş

This figure shows the co-authorship network connecting the top 25 collaborators of Arife Ulaş. A scholar is included among the top collaborators of Arife Ulaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arife Ulaş. Arife Ulaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ulaş, Arife, et al.. (2023). Lung Carcinoma Developing Afatinib-Associated Skin Reactions. 9(2). 112–116.
3.
Dede, Didem Şener, Hayriye Tatlı Doğan, Berrak Gümüşkaya, et al.. (2017). The association of programmed death-ligand 1 (PD-L1), programmed cell death (PD-1), tumor infiltrating lymphocytes(TILs) and isocitrate dehydrogenase (IDH-1) mutation in glioblastome multiforme(GBM). Annals of Oncology. 28. v110–v110. 1 indexed citations
4.
Sılay, Kamile, Arife Ulaş, Ahmet Yalçın, et al.. (2016). Occult urinary incontinence in elderly women and its association with geriatric condition.. PubMed. 20(3). 447–51. 15 indexed citations
5.
Erçelep, Özlem, İbrahim Vedat Bayoğlu, Halil Kavgacı, et al.. (2016). Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology. Tumor Biology. 37(9). 12033–12038. 8 indexed citations
6.
Ulaş, Arife, et al.. (2015). Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?. PubMed. 20(3). 714–22. 41 indexed citations
7.
Avcı, Nilüfer, et al.. (2015). Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.. PubMed. 20(1). 45–9. 15 indexed citations
8.
Ulaş, Arife, et al.. (2015). Risk Factors for Skeletal-Related Events in Patients with Non-Small Cell Lung Cancer Patients with Bone Metastases. Annals of Oncology. 26. i29–i29. 1 indexed citations
9.
Odabaş, Hatice, Arife Ulaş, Mevlüde İnanç, et al.. (2015). Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology. Tumor Biology. 36(12). 9641–9648. 5 indexed citations
10.
Sılay, Kamile, et al.. (2015). Hospitalization Risk According to Geriatric Assessment and Laboratory Parameters in Elderly Hematologic Cancer Patients. Asian Pacific Journal of Cancer Prevention. 16(2). 783–786. 10 indexed citations
11.
Ulaş, Arife, et al.. (2015). Lung Cancer in Women, a Different Disease: Survival Differences by Sex in Turkey. Asian Pacific Journal of Cancer Prevention. 16(2). 815–822. 17 indexed citations
12.
Ulaş, Arife, Fatma Paksoy Türköz, Kamile Sılay, et al.. (2014). A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer. PLoS ONE. 9(12). e114471–e114471. 40 indexed citations
13.
Demırcı, Umut, Uğur Çoşkun, Faysal Dane, et al.. (2014). Docetaxel and Cisplatin in First Line Treatment of Patients with Unknown Primary Cancer: A Multicenter Study of the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention. 15(4). 1581–1584. 8 indexed citations
14.
Üyetürk, Ümmügül, Berna Öksüzoğlu, İbrahim Türker, et al.. (2014). Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology. Medical Oncology. 31(4). 929–929. 5 indexed citations
15.
Çoşkun, Uğur, Mevlüde İnanç, Tülay Akman, et al.. (2013). Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab. Oncology Research and Treatment. 36(10). 554–558. 2 indexed citations
16.
Bılıcı, Ahmet, Mevlüde İnanç, Arife Ulaş, et al.. (2013). Clinical and Pathologic Features of Patients with Rare Ovarian Tumors: Multi-Center Review of 167 Patients by the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention. 14(11). 6493–6499. 11 indexed citations
17.
Ustaalıoğlu, Bala Başak Öven, Olçun Ümit Ünal, Nedim Turan, et al.. (2013). Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences. Asian Pacific Journal of Cancer Prevention. 14(11). 6287–6292. 11 indexed citations
18.
19.
Ustaalıoğlu, Bala Başak Öven, Arife Ulaş, Nedim Turan, et al.. (2012). Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey. Thoracic Cancer. 4(2). 161–166. 2 indexed citations
20.
Turan, Nedim, Mustafa Beneklı, Doğan Koca, et al.. (2012). Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer. Oncology. 84(1). 14–21. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danila Comandini Breakdown of academic impact, for papers by Zachary Burningham Breakdown of academic impact, for papers by P. Foa Breakdown of academic impact, for papers by Gina Villani Breakdown of academic impact, for papers by A.C. Braud Breakdown of academic impact, for papers by Paul Donnellan Breakdown of academic impact, for papers by Yukiya Narita Breakdown of academic impact, for papers by Alfonso Yubero Breakdown of academic impact, for papers by Olivier Capitain Breakdown of academic impact, for papers by Frédéríc Gomez
Rankless by CCL
2026